GRHL2调控的microRNA 122保护小鼠和患者的肝脏免受乙醇诱导的肝病
该研究分析酒精性肝病(ALD)患者和小鼠模型中microRNA 122(MIR122)的表达变化,发现ALD患者和小鼠肝脏MIR122水平降低,GRHL2升高抑制MIR122转录,过表达MIR122可减轻小鼠肝损伤,而抗MIR122加重损伤,MIR122通过降低HIF1α保护肝脏。
要点
- ALD患者和小鼠肝脏MIR122水平较对照降低,GRHL2水平升高且与MIR122降低相关。
- 小鼠肝细胞过表达MIR122可显著降低血清ALT水平并减轻肝脂肪变性和纤维化。
- 抗MIR122加重乙醇喂养小鼠的肝脂肪变、炎症和血清ALT水平。
核心结论
- ALD患者和乙醇诱导肝病小鼠肝脏MIR122水平较对照降低。
- GRHL2抑制MIR122转录,且在ALD小鼠和患者肝脏中升高。
- 抗MIR122表达加重乙醇喂养小鼠的肝损伤严重程度。
- MIR122可能通过降低HIF1α水平保护肝脏免受乙醇诱导的损伤。
研究设计与样本
- 获取12例ALD伴肝硬化患者和9例健康对照的肝脏样本,进行组织学和免疫组化分析。
- C57Bl/6小鼠给予Lieber-DeCarli液体饲料含乙醇8周建立ALD模型,部分小鼠同时注射CCl4 8周以增加肝纤维化。
- 第28天,对乙醇诱导肝病和晚期纤维化小鼠及对照注射表达pri-MIR122的腺相关病毒8型载体或对照载体。
- 部分小鼠在乙醇喂养前2周注射表达抗MIR122的载体以敲低其表达。
- 收集血清和肝组织,分析肝细胞和肝脏单核细胞,并进行计算机模拟分析和Huh-7细胞染色质免疫沉淀定量PCR。
主要发现
- ALD患者和小鼠肝脏MIR122水平较对照降低。
- 过表达MIR122显著降低乙醇诱导肝病和晚期纤维化小鼠的血清ALT水平并减轻肝脂肪变性和纤维化,与对照载体小鼠相比。
- 乙醇喂养通过增加转录因子GRHL2剪接形式表达降低pri-MIR122表达。
- ALD患者肝脏GRHL2水平较对照升高,且升高与MIR122水平降低相关。
- 抗MIR122注射小鼠较对照载体小鼠肝脂肪变、炎症和血清ALT水平增加。
关键数值与推荐
- ALD患者肝脏MIR122水平较健康对照降低。
- 乙醇喂养小鼠肝脏MIR122水平较对照饮食小鼠降低。
- 过表达MIR122小鼠血清ALT水平和肝脂肪变、纤维化较对照载体小鼠显著降低。
- 抗MIR122小鼠肝脂肪变、炎症和血清ALT水平较对照载体小鼠增加。
- ALD患者和小鼠肝脏HIF1α mRNA水平较对照升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Chronic, excessive alcohol consumption leads to alcoholic liver disease (ALD) characterized by steatosis, inflammation, and eventually cirrhosis. The hepatocyte specific microRNA 122 (MIR122) regulates hepatocyte differentiation and metabolism. We investigated whether an alcohol-induced decrease in level of MIR122 contributes to development of ALD. METHODS: We obtained liver samples from 12 patients with ALD and cirrhosis and 9 healthy individuals (controls) and analyzed them by histology and immunohistochemistry. C57Bl/6 mice were placed on a Lieber-DeCarli liquid diet, in which they were fed ethanol for 8 weeks, as a model of ALD, or a control diet. These mice were also given injections of CCl4, to increase liver fibrosis, for 8 weeks. On day 28, mice with ethanol-induced liver disease and advanced fibrosis, and controls, were given injections of recombinant adeno-associated virus 8 vector that expressed the primary miR-122 transcript (pri-MIR122, to overexpress MIR122 in hepatocytes) or vector (control). Two weeks before ethanol feeding, some mice were given injections of a vector that expressed an anti-MIR122, to knock down its expression. Serum and liver tissues were collected; hepatocytes and liver mononuclear cells were analyzed by histology, immunoblots, and confocal microscopy. We performed in silico analyses to identify targets of MIR122 and chromatin immunoprecipitation quantitative polymerase chain reaction analyses in Huh-7 cells. RESULTS: Levels of MIR122 were decreased in liver samples from patients with ALD and mice on the Lieber-DeCarli diet, compared with controls. Transgenic expression of MIR122 in hepatocytes of mice with ethanol-induced liver disease and advanced fibrosis significantly reduced serum levels of alanine aminotransferase (ALT) and liver steatosis and fibrosis, compared with mice given injections of the control vector. Ethanol feeding reduced expression of pri-MIR122 by increasing expression of the spliced form of the transcription factor grainyhead like transcription factor 2 (GRHL2) in liver tissues from mice. Levels of GRHL2 also were increased in liver tissues from patients with ALD, compared with controls; increases correlated with decreases in levels of MIR122 in human liver. Mice given injections of the anti-MIR122 before ethanol feeding had increased steatosis, inflammation, and serum levels of alanine aminotransferase compared with mice given a control vector. Levels of hypoxia-inducible factor 1 alpha (HIF1α) mRNA, a target of MIR122, were increased in liver tissues from patients and mice with ALD, compared with controls. Mice with hepatocyte-specific disruption of Hif1α developed less-severe liver injury following administration of ethanol, injection of anti-MIR122, or both. CONCLUSIONS: Levels of MIR122 decrease in livers from patients with ALD and mice with ethanol-induced liver disease, compared with controls. Transcription of MIR122 is inhibited by GRHL2, which is increased in livers of mice and patients with ALD. Expression of an anti-MIR122 worsened the severity of liver damage following ethanol feeding in mice. MIR122 appears to protect the liver from ethanol-induced damage by reducing levels of HIF1α. These processes might be manipulated to reduce the severity of ALD in patients.
引用
- Satishchandran A, Ambade A, Rao S, et al. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease. Gastroenterology. 2017. PMID: 28987423. doi:10.1053/j.gastro.2017.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。